Phase I clinical trial of imigliptin dihydrochloride in healthy volunteers and in Type 2 diabetes patients.
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Imigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; First in man
- Sponsors Sihuan Pharmaceutical Holdings Group
- 04 Aug 2016 Results published in the XuanZhu Pharma Media Release.
- 12 Nov 2014 New trial record